Nationwide Recall Issued for Cetirizine Tablets Due to Ranitidine Contamination

The FDA has announced a nationwide recall of specific lots of Cetirizine Hydrochloride Tablets USP 5 mg, a common over-the-counter antihistamine. The recall stems from potential cross-contamination with ranitidine, a medication for ulcers and reflux. This contamination poses a risk of severe adverse reactions, such as hypotension and shortness of breath, for individuals sensitive to ranitidine.